You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Characteristics of nine post-LT HEV seroconverting patients with a history of HCV infection

From: Prevalence and clinical consequences of Hepatitis E in patients who underwent liver transplantation for chronic Hepatitis C in the United States

  Age at LT Gender Ethnicity LT year Type of serologic conversion Conversion year (from LT) Post-LT HCV treatment Treatment year post-LT Treatment medication
Pt 1 46 Male Caucasian 1998 IgM 5 Yes 1-5 IFN + RBV
Pt 2 48 Male Caucasian 1998 IgG 1 Yes 0-1 IFN + RBV
Pt 3 39 Male Native Hawaiian 2000 IgG 5 Yes 2-3 IFN + RBV
Pt 4 36 Female Caucasian 2001 IgG 1 Yes 0-1 IFN + RBV
Pt 5 47 Male Other NS 2001 IgG 1 Yes 0 IFN
Pt 6 51 Male Caucasian 2001 IgG 5 Yes 2-4 IFN + RBV
Pt 7 47 Male Caucasian 2003 IgG 3 Yes 1-4 IFN + RBV
Pt 8 51 Male Caucasian 2004 IgG 5 Yes 0-3 IFN + RBV
Pt 9 54 Male Caucasian 2009 IgG 1 No N/A N/A
  1. LT Liver transplant, HEV Hepatitis E virus, HCV Hepatitis C virus, IFN (peg) interferon, RBV ribavirin, Other NS Other than Caucasian, Hispanic, Black or Asian, not specified, N/A not applicable